1. 超选择性眼动脉介入溶栓成功救治透明质酸隆鼻 致单眼失明一例报告及文献回顾.
- Author
-
李坤, 孙慧, 管晓玉, 杨峤, 胡晓莺, and 贺西亮
- Subjects
- *
RETINAL artery , *OPHTHALMIC artery , *FIBRINOLYTIC agents , *DERMAL fillers , *LITERATURE reviews , *LOW vision - Abstract
Objective To report a case of successful rescue of right eye blindness induced by hyaluronic acid (HA) filler rhinoplasty using super-selective intra-artery thrombolytic therapy (IAT) of the ophthalmic artery, and explore the characteristics, safety, and efficacy of super-selective ophthalmic artery IAT in treating ophthalmic artery embolism caused by HA through a review of the literature. Methods In July 2023, Qingdao Eighth People's Hospital successfully treated a case of blindness caused by central retinal artery embolism due to HA with super-selective IAT of the ophthalmic artery, and the patient's vision returned to normal. A search was conducted in the database using the following keywords: cosmetic filler injection, hyaluronic acid (HA), soft tissue augmentation, blindness OR ophthalmoplegia, visual impairment OR retinal artery occlusion OR ophthalmic artery occlusion, hyaluronidase, intra-arterial thrombolytic therapy. The time limit for the search was from January 2010 to July 2023. The statistics included researchers, patient conditions, patient complication information, treatment information, and treatment outcomes. Results A total of 10 studies were included, with 6 from Chinese teams and 4 from Korean teams. These studies encompassed 114 patients including 1 case from the present study. All patients experienced vision loss or even blindness and received super-selective IAT of the ophthalmic artery. The thrombolytic agents used were hyaluronidase (93 cases) or urokinase (1 case), or a combination of both (17 cases). Currently, there is no unified protocol for the optimal dosage, dilution concentration, and treatment duration. When analysing the time of the first super-selective ophthalmic artery IAT treatment, the visual acuity before consultation, and the results of visual acuity improvement for patients with improved vision, it was found that the visual acuity improvement was not significantly correlated with whether or not the first super-selective ophthalmic artery IAT was performed within the time window (P>0.05), but significantly correlated with the extent of the patients' impaired visual acuity at the time of the super-selective ophthalmic artery IAT (P<0.05). Conclusion Super-selective IAT of the ophthalmic artery, using hyaluronidase and urokinase, can recanalize ophthalmic artery and its branches that have been embolized due to HA facial fillers, thereby restoring blood flow and improving impaired vision. However, the effect is limited. As an effective treatment for thrombolysis of HA-related intra-arterial embolism, super-selective ophthalmic artery IAT is still worth actively trying. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF